This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis
Scientific Reports Open Access 17 May 2022
-
A situation analysis of competences of research ethics committee members regarding review of research protocols with complex and emerging study designs in Uganda
BMC Medical Ethics Open Access 26 September 2021
-
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
Nature Communications Open Access 01 December 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dash, P.K. et al. AIDS 26, 2135–2144 (2012).
Gautam, N. et al. Antimicrob. Agents Chemother. 57, 3110–3120 (2013).
Williams, J. et al. Nanomedicine 8, 1807–1813 (2013).
Andrews, C.D. et al. Science 343, 1151–1154 (2014).
Rights and permissions
About this article
Cite this article
Dolgin, E. Long-acting HIV drugs advanced to overcome adherence challenge. Nat Med 20, 323–324 (2014). https://doi.org/10.1038/nm0414-323
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0414-323
This article is cited by
-
Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis
Scientific Reports (2022)
-
A situation analysis of competences of research ethics committee members regarding review of research protocols with complex and emerging study designs in Uganda
BMC Medical Ethics (2021)
-
Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
Nature Communications (2020)
-
Creation of a long-acting nanoformulated dolutegravir
Nature Communications (2018)
-
Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City
AIDS and Behavior (2018)